Clik here to view.
Delaware Court Finds That THERAVECTYS is Reasonably Likely to Succeed on the...
PARIS THERAVECTYS announced today a ruling by the Delaware Court of Chancery on the motion for preliminary injunction filed by THERAVECTYS against Immune Design Corp. (“IDC”) in a lawsuit filed in...
View ArticleClik here to view.
Open Monoclonal Technology Announces OmniAb™ Alliance with Celgene
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT) today announced a license that provides Celgene Corporation (Celgene) with unlimited access to OMT’s proprietary OmniRat®, OmniMouse® and...
View ArticleClik here to view.
デラウェア州裁判所が、Immune Design Corpによる違法な妨害を訴えるテラヴェクティスに本案勝訴の合理的な可能性を認める
パリ （ビジネスワイヤ） — テラヴェクティスは本日、デラウェア州衡平法裁判所が下した裁定を発表しました。裁定は2014年7月にテラヴェクティスがImmune Design Corp.（IDC）を相手取って起こした訴訟における予備的差し止め命令の申し立てに関するものです。訴訟でテラヴェクティスは、IDCがHenogen...
View ArticleClik here to view.
Lenovo CEO Yang Yuanqing to Join Fight against Cancer in China
SHANGHAI Lenovo (SEHK:0992) (Pink Sheets:LNVGY) today announced that Chairman and CEO Yang Yuanqing will join the CEO Roundtable on Cancer, an international non-profit organization focused on...
View ArticleClik here to view.
Takeda Licenses Rights to Use ImmunoGen, Inc.’s Novel Antibody-Drug Conjugate...
CAMBRIDGE & WALTHAM, Mass. Takeda Pharmaceutical Company Limited (TSE:4502) and ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer therapeutics using its...
View ArticleClik here to view.
法国药管局核准THERAVECTYS按GMP标准生产用于临床的慢病毒载体和CAR-T细胞治疗药物
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 巴黎 (美国商业资讯) —...
View ArticleClik here to view.
テラヴェクティスがGMP規格の下で臨床使用／CAR-T細胞療法向けレンチウイルスベクターを生産するための認可をフランス医薬品当局から取得
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 パリ （ビジネスワイヤ） —...
View ArticleClik here to view.
厚生労働省よりノボキュア社オプチューン（販売名：NovoTTF-100Aシステム）が再発膠芽腫の治療用機器として薬事承認を取得しましたので下記の通りご案内...
ジャージー セント・ヘリア （ビジネスワイヤ）–がん治療の医療機器開発を進めるノボキュア社は本日、厚生労働省から、再発膠芽腫の治療に使用する治療電場を発生させる装置であるオプチューンの承認を取得したことを発表しました。...
View ArticleClik here to view.
Solasia Acquires Exclusive License and Distribution Rights From Camurus for...
LUND, Sweden & TOKYO Camurus AB (“Camurus”) and Solasia Pharma K.K. (“Solasia”) jointly announced today that they have entered into a license and distribution agreement for episil® oral liquid,...
View ArticleClik here to view.
Hitachi Aloka Medical, Ltd. and iVu Imaging Corp Announce Exclusive Agreement...
TOKYO Hitachi Aloka Medical, Ltd. (Headquartered in Tokyo, Japan, President: Mr. Minoru Yoshizumi) and iVu Imaging Corporation announced the signing of an agreement making Hitachi Aloka Medical,...
View ArticleClik here to view.
Solasia从Camurus获得episil®口服液在日本和中国的独家授权和分销权
瑞典隆德和东京 (美国商业资讯)–Camurus AB (“Camurus”)和Solasia Pharma K.K. (“Solasia”)今天联合宣布，两家公司已签署一项有关episil®口服液的授权和分销协议，该口服液是一种有效治疗口腔粘膜炎和其他口腔病灶的独特药物，口腔粘膜炎是部分抗癌疗法的一种治疗限制性副作用。...
View ArticleClik here to view.
Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing...
BEIJING & SAN DIEGO Berry Genomics Co., Ltd. announced today that Hangzhou Berry Genomics, a subsidiary of Berry Genomics Co., Ltd., has received premarket clearance from the Chinese Food and...
View ArticleClik here to view.
Provision Healthcare and Tianjin Taishan Cancer Hospital Partner to Develop...
KNOXVILLE, Tenn. Provision Healthcare has signed a joint agreement with the Tianjin Taishan Cancer Hospital (International Personalized Cancer Center, “IPCC”) in northern China to build the first...
View ArticleClik here to view.
International Forum on Consciousness: Conscious Evolution: The Awakening
MADISON, Wis. Conscious Evolution: The Awakening is the theme for this year’s International Forum on Consciousness, to be held May 7-8 in Fitchburg/Madison, Wisconsin. Hosted by the...
View ArticleClik here to view.
エリテックが2014年通期のビジネスアップデートと決算を報告
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（ADR:EYRYY）（Euronext Paris: ERYP & OTC US:...
View ArticleClik here to view.
Clik here to view.
Promega Nano-Glo® Dual-Luciferase® Reporter Assay Enables More Sensitive...
MADISON, Wis. Promega Corporation announces the launch of the new Nano-Glo® Dual-Luciferase® Reporter (NanoDLR™) Assay, a two-reporter system that incorporates NanoLuc® luciferase technology,...
View ArticleClik here to view.
Provectus Biopharmaceuticals to Present at 7th Annual International...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
IBA and Toshiba Sign Strategic Partnership in Particle Therapy
LOUVAIN-LA-NEUVE, Belgium & TOKYO IBA (Ion Beam Applications S.A.) and Toshiba Corporation (TOKYO:6502) today announce the signing of a global collaboration to expand access to advanced particle...
View ArticleClik here to view.
IBA与东芝签署粒子疗法战略伙伴关系
比利时LOUVAIN-LA-NEUVE和东京 (美国商业资讯) — IBA (Ion Beam Applications S.A.)与东芝公司(TOKYO:6502)今天宣布签署一份全球合作协议，以拓展世界各地的先进粒子疗法可及性。东芝医疗系统公司(Toshiba Medical Systems...
View Article